123 related articles for article (PubMed ID: 34180556)
1. Xanthatin inhibits human colon cancer cells progression via mTOR signaling mediated energy metabolism alteration.
Li L; Liu P; Xie Y; Liu Y; Chen Z; Geng Y; Zhang L
Drug Dev Res; 2022 Feb; 83(1):119-130. PubMed ID: 34180556
[TBL] [Abstract][Full Text] [Related]
2. TMT-Based Quantitative Proteomic Analysis Identified Proteins and Signaling Pathways Involved in the Response to Xanthatin Treatment in Human HT-29 Colon Cancer Cells.
Geng Y; Li L; Liu P; Chen Z; Shen A; Zhang L
Anticancer Agents Med Chem; 2022; 22(5):887-896. PubMed ID: 34488591
[TBL] [Abstract][Full Text] [Related]
3. Xanthatin mediates G
Geng YD; Zhang L; Wang GY; Feng XJ; Chen ZL; Jiang L; Shen AZ
Nat Prod Res; 2020 Sep; 34(18):2616-2620. PubMed ID: 30587055
[TBL] [Abstract][Full Text] [Related]
4. Xanthatin suppresses pancreatic cancer cell growth via the ROS/RBL1 signaling pathway: In vitro and in vivo insights.
Geng Y; Liu P; Xie Y; Liu Y; Zhang X; Hou X; Zhang L
Phytomedicine; 2023 Oct; 119():155004. PubMed ID: 37562091
[TBL] [Abstract][Full Text] [Related]
5. Xanthatin anti-tumor cytotoxicity is mediated via glycogen synthase kinase-3β and β-catenin.
Tao L; Sheng X; Zhang L; Li W; Wei Z; Zhu P; Zhang F; Wang A; Woodgett JR; Lu Y
Biochem Pharmacol; 2016 Sep; 115():18-27. PubMed ID: 27321043
[TBL] [Abstract][Full Text] [Related]
6. Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming.
Wang P; Jin JM; Liang XH; Yu MZ; Yang C; Huang F; Wu H; Zhang BB; Fei XY; Wang ZT; Xu R; Shi HL; Wu XJ
Acta Pharmacol Sin; 2022 Jun; 43(6):1581-1593. PubMed ID: 34462561
[TBL] [Abstract][Full Text] [Related]
7. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
[TBL] [Abstract][Full Text] [Related]
8. Xanthatin induces glioma cell apoptosis and inhibits tumor growth via activating endoplasmic reticulum stress-dependent CHOP pathway.
Ma YY; Di ZM; Cao Q; Xu WS; Bi SX; Yu JS; Shen YJ; Yu YQ; Shen YX; Feng LJ
Acta Pharmacol Sin; 2020 Mar; 41(3):404-414. PubMed ID: 31700088
[TBL] [Abstract][Full Text] [Related]
9. Xanthatin inhibits non-small cell lung cancer proliferation by breaking the redox balance.
Xie Y; Zhu X; Liu P; Liu Y; Geng Y; Zhang L
Drug Dev Res; 2022 Aug; 83(5):1176-1189. PubMed ID: 35466412
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antifungal activity of new Michael-type amino derivatives of xanthatin, a natural sesquiterpene lactone from Xanthium strumarium L.
Zhi XY; Song LL; Liang J; Wei SQ; Li Y; Zhang Y; Hao XJ; Cao H; Yang C
Bioorg Med Chem Lett; 2022 Jan; 55():128481. PubMed ID: 34852242
[TBL] [Abstract][Full Text] [Related]
11. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells.
Zhang C; Yang L; Geng YD; An FL; Xia YZ; Guo C; Luo JG; Zhang LY; Guo QL; Kong LY
Oncotarget; 2016 May; 7(19):27819-37. PubMed ID: 27056897
[TBL] [Abstract][Full Text] [Related]
12. (--)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells.
Takeda S; Matsuo K; Yaji K; Okajima-Miyazaki S; Harada M; Miyoshi H; Okamoto Y; Amamoto T; Shindo M; Omiecinski CJ; Aramaki H
Chem Res Toxicol; 2011 Jun; 24(6):855-65. PubMed ID: 21568272
[TBL] [Abstract][Full Text] [Related]
13. (-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species.
Takeda S; Noguchi M; Matsuo K; Yamaguchi Y; Kudo T; Nishimura H; Okamoto Y; Amamoto T; Shindo M; Omiecinski CJ; Aramaki H
Toxicology; 2013 Mar; 305():1-9. PubMed ID: 23313378
[TBL] [Abstract][Full Text] [Related]
14. Xanthatin, a novel potent inhibitor of VEGFR2 signaling, inhibits angiogenesis and tumor growth in breast cancer cells.
Yu Y; Yu J; Pei CG; Li YY; Tu P; Gao GP; Shao Y
Int J Clin Exp Pathol; 2015; 8(9):10355-64. PubMed ID: 26617743
[TBL] [Abstract][Full Text] [Related]
15. Xanthatin induces G2/M cell cycle arrest and apoptosis in human gastric carcinoma MKN-45 cells.
Zhang L; Tao L; Ruan J; Li W; Wu Y; Yan L; Zhang F; Fan F; Zheng S; Wang A; Lu Y
Planta Med; 2012 Jun; 78(9):890-5. PubMed ID: 22532019
[TBL] [Abstract][Full Text] [Related]
16. Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells.
Zhang L; Ruan J; Yan L; Li W; Wu Y; Tao L; Zhang F; Zheng S; Wang A; Lu Y
Molecules; 2012 Mar; 17(4):3736-50. PubMed ID: 22450683
[TBL] [Abstract][Full Text] [Related]
17. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
18. Concerted suppression of STAT3 and GSK3β is involved in growth inhibition of non-small cell lung cancer by Xanthatin.
Tao L; Fan F; Liu Y; Li W; Zhang L; Ruan J; Shen C; Sheng X; Zhu Z; Wang A; Chen W; Huang S; Lu Y
PLoS One; 2013; 8(11):e81945. PubMed ID: 24312384
[TBL] [Abstract][Full Text] [Related]
19. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
[TBL] [Abstract][Full Text] [Related]
20. Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells.
Tao L; Cao Y; Wei Z; Jia Q; Yu S; Zhong J; Wang A; Woodgett JR; Lu Y
Toxicol Appl Pharmacol; 2017 Dec; 337():85-94. PubMed ID: 29074359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
